We have previously shown that increased MPO can produce favourable conditions for tumour progression, eliciting a pro‐fibrogenic and pro‐angiogenic tumour microenvironment in a mouse model of breast cancer.20, 22. This evidence concerns the gene MPO and breast carcinoma.